CCND1 locus is found in 15%-25% of newly diagnosed MM cases, and is associated with a lymphoplasmacytic morphology, frequent CD20 expression, an indolent clinical course, and a relatively favorable outcome when no additional cytogenetic abnormalities are present. 5 In contrast, t(4;14)(p16.3;q32) involving the NSD2/ MMSET/FGFR3 locus is found in 10%-15% of MM cases, and is associated with a frequent deletion of chromosome 13q, a common
IgA subtype, and a relatively unfavorable outcome even in patients receiving high-dose therapy with autologous stem cell transplantation. 6, 7 The overall prognosis of MM patients harboring t (4;14) may improve after the introduction of proteasome inhibitors (PIs) such as bortezomib. However, the overall survival rate is <50% at 5 y even with bortezomib treatment. 8 Another important chromosomal aberration observed in c. 5% of MM cases is t(14;16)(q32;q23)
involving the MAF locus. 1, [9] [10] [11] Many studies have suggested that MM cases carrying t(14;16) are associated with hypercalcemia and an unfavorable outcome as well as a lower frequency of extramedullary tumor formation even in the era of clinical innovations such as the use of PIs and immunomodulatory drugs (IMiDs).
8,12
Due to difficulties in obtaining mitotic figures, cytogenetic analysis is not an optimal method for detecting gene rearrangements.
Detection is usually carried out using a fluorescent in situ hybridization (FISH) technique performed using fresh tumor samples fixed 
| MATERIAL S AND ME THODS

| Study cohorts
We retrieved archival MM and non-neoplastic cases with bone marrow specimens from the files of the Department of Pathology and Molecular Diagnostics and Department of Hematology and
Oncology, Nagoya City University Graduate School of Medical Sciences. This study was approved by the Nagoya City University
Internal Review Board. The cases were pathologically evaluated and the diagnosis was confirmed by expert hematopathologists (AM and HI) according to the criteria of the WHO classification of MM. 14 All cases were within the morphologic boundaries of MM, were positive for MM-associated antigens, and were restricted to either kappa or lambda light chain. All specimens used in this study were obtained by bone marrow aspiration, fixed in formalin, and embedded in paraffin.
In the preliminary analysis, DNA extracted from FFPE sections of MM cases was subjected to amplification of a fragment of the PLZF gene (300 bp) by the polymerase chain reaction to confirm DNA quality. 15 Cases negative for the amplification were excluded. The specimens were then separated into cohorts 1 and 2. 
| Cohort 1
| Tissue FISH analysis using paraffin sections
When a sufficient number of neoplastic plasma cells (MM cells > 30%), as determined with serial H&E and IHC sections, were present in the bone marrow FFPE tissues, standard tissue FISH analysis for gene splits was performed as we previously described. 16 In brief, bone marrow sections were deparaffinized, heat-treated, and digested in pepsin 
| Sequential FICTION-whole-slide imaging and data processing
When a small number of plasma cells (MM cells < 30%) were present in FFPE specimens, it was necessary to identify MM cell nuclei for accurate FISH evaluation. For this purpose, we used a sequential Figure S1 ), which we recently developed and have described elsewhere. 17 This technique enables us to retrieve WSI data of H&E, immunofluorescence (IF),
FICTION-whole-slide imaging (WSI) technique (
and FISH, using a single FFPE tissue section. Briefly, after deparaffinization, an MM tissue section was stained with H&E. WSI data of the H&E section were obtained using an automated fluorescence image analyzer (IN Cell Analyzer 6000, GE Healthcare), which was equipped with a ×60 objective lens. The H&E-stained section was then subjected to IF for CD138; the section was heat-treated in 10 mmol/L citric acid buffer (pH 6.0) to inactivate the H&E dyes and for antigen retrieval. Next, the section was reacted with anti-CD138
antibody, incubated with Cy3-labeled second antibody, and finally stained with diaminophenilindole. The IF-WSI data of the MM section were obtained using the automated fluorescence image analyzer. The IF-stained section was then subjected to FISH analysis.
The tissue section was heat treated and protease digested, and FISH was performed as described above. FISH-WSI data were obtained again using the automated image analyzer. 
| Statistical analysis
Statistical evaluation of data from 2 groups was carried out using Fisher's exact test. Cut-off points for IHC were determined with receiver operating characteristics (ROC) curves. A value of P < .05 in each test was regarded as statistically significant. All analyses were two-tailed and carried out using statistical packages JMP version 14.2.0 (SAS Institute) and DANS version 10.7 (Sugimoto Data Analysis Service).
| RE SULTS
| Cohort 1
In curves to obtain the highest sensitivity and specificity for estimating the presence of respective gene rearrangements ( Table 1 ). The distribution of IHC-positive cases is shown in Table S1 .
For CCND1-IHC, the cut-off point was set to 5% by ROC analysis. The area under the curve (AUC) was 1.00 (Table 1) , and the sensitivity, specificity, and accuracy for detecting CCND1 gene rearrangement using CCND1-IHC were calculated to be 1.00, 1.00, and 1.00 (Table 2 ). For NSD2-IHC, the cut-off point was similarly set to 10% and the AUC was .97 (Table 1 ). The sensitivity, specificity, and accuracy for detecting NSD2 gene rearrangement using NSD2-IHC were calculated to be .95, .96, and .96 (Table 2 ). For MAF-IHC, the cut-off point was set to 10% by ROC analysis and the AUC was .933 (Table 1 ). The sensitivity, specificity, and accuracy for detecting MAF gene rearrangement using MAF-IHC were calculated to be .90, .98, and .97 ( Table 2 ). The results of cohort 1 are summarized in Figure S2 .
| Cohort 2
Cohort 2 included 120 MM cases in which the gene status was unknown, and all cases were subjected to double-IHC for CD138
and either of CCND1, NSD2, or MAF. When the IHC cut-off points determined in Cohort 1 were employed, CCND1, NSD2, and MAF were positive in 28, 13, and 4 cases, respectively, and the remaining 75 MM cases were negative for all 3 molecules. All MM cases (n = 120) were then subjected to tissue FISH analysis using FFPE tumor sections. In 28 CCND1-IHC-positive cases, 26 (93%) cases Tables 3, S1 , and Figure S3 . When MM cases included in cohorts 1 and 2 were combined (190 cases in total), an IHC sensitivity, specificity, and accuracy for CCND1, NSD2, and MAF were calculated to be 100%, 99%, and 99%; 94%, 98%, and 97%; and 93%, 99%, and 99%, respectively (Tables S1 and S2 ).
| Cases showing a discordance between FISH and IHC
In cohorts 1 and 2, there were 9 cases in which there were differences between FISH and IHC results (Table 4) . One case positive for CCND1 on FISH was positive for CCND1 and NSD2 on IHC. Three cases positive on FISH for NSD2 were positive for NSD2 and MAF (n = 1) and negative for the 3 molecules on IHC (n = 2). Two cases positive for MAF using FISH were positive for NSD2 and MAF (n = 1) and negative for the 3 molecules using IHC (n = 1). Three cases negative for gene rearrangements on FISH were positive for CCND1 (n = 2) and NSD2 (n = 1) using IHC.
| D ISCUSS I ON
In the cohort 1 analysis, we performed IHC for CCND1, NSD2, and MAF in controls and cases proven to be positive and negative by means of FISH. CCND1, NSD2, and MAF overexpression were highly associated with the respective gene rearrangements. Using ROC analysis, we determined the cut-off points for each IHC, which allowed for estimation of these gene rearrangements with sensitivities ≥ 90% and specificities ≥ 96%. Subsequently, using cohort 2 (120 MM cases in which the gene status was unknown),
we performed IHC for CCND1, NSD2, and MAF, and tissue FISH for CCND1, NSD2, and MAF genes. The IHC sensitivity and specificity for the 3 gene rearrangements were calculated to be ≥92%
and ≥98%, respectively. Our findings suggested that CCND1, NSD2, and MAF gene rearrangements can be successfully detected using the IHC assay. It should be noted that double-IHC for CD138
and either of CCND1, NSD2, or MAF should be performed for ac- Compared with using fresh tissue, FFPE tissue specimens have many advantages: they can be routinely prepared, are easily stored, and are superior in morphology. However, there are some issues to be considered when FFPE samples are applied to FISH assays. First, FISH assays using FFPE sections are technically more complicated than those using fresh cells. Second, in some aspirates of cohort 1 (approximately 3%), the quality of the DNA was not sufficiently high. DNA degradation is more prominent in bone marrow biopsy specimens, in which bony tissue decalcification is required. This may be partly resolved by using an EDTA solution, which is a less powerful decalcifier but superior in nucleic acid preservation compared the conventional formic acid. 25 Third, the thickness of FFPE sections (4 μm in our study) is usually less than half of the tumor nuclei, resulting in a loss of some FISH signals localized in the nuclei ( Figure S4 ). To partly overcome this issue, we used break-apart type FISH probes. The number of FISH signals with a break-apart probe assay is less than that required with a dual-color fusion probe assay, leading to a more accurate FISH signal evaluation.
Another issue in using FFPE sections for FISH is that it is usually difficult to perform using purified plasma cells or to carry out FISH combined with IF to detect cytoplasmic light chains. 
